183 related articles for article (PubMed ID: 18685261)
1. Recommendations for the long-term treatment of psoriasis with infliximab: a dermatology expert group consensus.
Reich K; Griffiths C; Barker J; Chimenti S; Daudén E; Giannetti A; Gniadecki R; Katsambas A; Langley R; Mrowietz U; Ogilvie A; Ortonne JP; Reider N; Saurat JH
Dermatology; 2008; 217(3):268-75. PubMed ID: 18685261
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of treatment with infliximab in patients with moderate-severe psoriasis and high needs of therapy. A retrospective study of 43 patients].
Puig L
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():30-5. PubMed ID: 19080989
[TBL] [Abstract][Full Text] [Related]
3. Long-term maintenance treatment of moderate-to-severe plaque psoriasis with infliximab in combination with methotrexate or azathioprine in a retrospective cohort.
Dalaker M; Bonesrønning JH
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):277-82. PubMed ID: 19207642
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of infliximab for severe recalcitrant psoriasis after 6 weeks of treatment.
DE Oliveira JP; Levy A; Morel P; Guibal F
J Dermatol; 2008 Sep; 35(9):575-80. PubMed ID: 18837702
[TBL] [Abstract][Full Text] [Related]
5. Recommendations for the use of etanercept in psoriasis: a European dermatology expert group consensus.
Boehncke WH; Brasie RA; Barker J; Chimenti S; Daudén E; de Rie M; Dubertret L; Giannetti A; Katsambas A; Kragballe K; Naeyaert JM; Ortonne JP; Peyrí J; Prinz JC; Saurat JH; Strohal R; van de Kerkhof P; Sterry W;
J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):988-98. PubMed ID: 16922950
[TBL] [Abstract][Full Text] [Related]
6. Recommendations for the treatment of nail psoriasis in patients with moderate to severe psoriasis: a dermatology expert group consensus.
Langley RG; Saurat JH; Reich K;
J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):373-81. PubMed ID: 22151734
[TBL] [Abstract][Full Text] [Related]
7. Duration of remission of biologic agents for chronic plaque psoriasis.
Langley RG; Gordon KB
J Drugs Dermatol; 2007 Dec; 6(12):1205-12. PubMed ID: 18189060
[TBL] [Abstract][Full Text] [Related]
8. Identifying the biologic closest to the ideal to treat chronic plaque psoriasis in different clinical scenarios: using a pilot multi-attribute decision model as a decision-support aid.
Guibal F; Iversen L; Puig L; Strohal R; Williams P
Curr Med Res Opin; 2009 Dec; 25(12):2835-43. PubMed ID: 19916728
[TBL] [Abstract][Full Text] [Related]
9. Review and expert opinion on prevention and treatment of infliximab-related infusion reactions.
Lecluse LL; Piskin G; Mekkes JR; Bos JD; de Rie MA
Br J Dermatol; 2008 Sep; 159(3):527-36. PubMed ID: 18627374
[TBL] [Abstract][Full Text] [Related]
10. Treatment of pustular psoriasis with infliximab.
Weishaupt C; Metze D; Luger TA; Ständer S
J Dtsch Dermatol Ges; 2007 May; 5(5):397-9. PubMed ID: 17451384
[TBL] [Abstract][Full Text] [Related]
11. Infliximab-induced remission of extensive plaque psoriasis.
Amital H; Ingber A; Rubinow A
Isr Med Assoc J; 2003 Nov; 5(11):827-8. PubMed ID: 14650114
[No Abstract] [Full Text] [Related]
12. [Infliximab].
Herrera E; Habicheyn S
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():7-13. PubMed ID: 19080986
[TBL] [Abstract][Full Text] [Related]
13. Use of infliximab in the treatment of psoriasis.
Lee MR; Cooper AJ
Australas J Dermatol; 2004 Aug; 45(3):193-5. PubMed ID: 15250904
[No Abstract] [Full Text] [Related]
14. Addition of low-dose methotrexate to infliximab in the treatment of a patient with severe, recalcitrant pustular psoriasis.
Barland C; Kerdel FA
Arch Dermatol; 2003 Jul; 139(7):949-50. PubMed ID: 12873907
[No Abstract] [Full Text] [Related]
15. [Infectious risk].
Calabuig E; Salavert M
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():14-22. PubMed ID: 19080987
[TBL] [Abstract][Full Text] [Related]
16. [Our experience with infliximab in reclacitrant cases of psoriasis].
Pereiro M; González-Vilas D; Sánchez-Aguilar D; Toribio J
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():43-7. PubMed ID: 19080991
[TBL] [Abstract][Full Text] [Related]
17. Severe recalcitrant nail psoriasis responding dramatically to infliximab: report of two patients.
Hussain W; Coulson I; Owen C
Clin Exp Dermatol; 2008 Jul; 33(4):520-2. PubMed ID: 18462438
[No Abstract] [Full Text] [Related]
18. Translating psoriasis treatment guidelines into clinical practice - the need for educational interventions and strategies for broad dissemination.
Nast A; Erdmann R; Pathirana D; Rzany B
J Eval Clin Pract; 2008 Oct; 14(5):803-6. PubMed ID: 19018914
[TBL] [Abstract][Full Text] [Related]
19. The use of infliximab in dermatology.
Rott S; Mrowietz U
J Dtsch Dermatol Ges; 2007 Aug; 5(8):655-60. PubMed ID: 17659038
[TBL] [Abstract][Full Text] [Related]
20. The relationship between quality of life and skin clearance in moderate-to-severe psoriasis: lessons learnt from clinical trials with infliximab.
Reich K; Griffiths CE
Arch Dermatol Res; 2008 Nov; 300(10):537-44. PubMed ID: 18784934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
